Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Gavriilaki, Eleni
, Sakellari, Ioanna, Labopin, Myriam, Bornhäuser, Martin, Hamladji, Rose-Marie, Casper, Jochen, Edinger, Matthias, Zák, Pavel, Yakoub-Agha, Ibrahim, Ciceri, Fabio, Schroeder, Thomas, Zuckerman, Tsila, Kobbe, Guido, Yeshurun, Moshe, Narni, Franco, Finke, Jürgen, Diez-Martin, Jose Luiz, Berceanu, Ana, Hilgendorf, Inken
, Verbeek, Mareike, Olivieri, Attilio, Savani, Bipin, Spyridonidis, Alexandros, Nagler, Arnon and Mohty, Mohamad
(2023)
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP).
Bone Marrow Transplantation 58 (10), pp. 1084-1088.
Date of publication of this fulltext: 18 Mar 2025 10:11
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Bone Marrow Transplantation | ||||
| Publisher: | SPRINGERNATURE | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 58 | ||||
| Number of Issue or Book Chapter: | 10 | ||||
| Page Range: | pp. 1084-1088 | ||||
| Date | 2023 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 76225 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric